Life for a Child Program, Diabetes Australia

Quick facts

Marketed products

• biosimilar insulin glargine · Diabetes
  Biosimilar insulin glargine is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and lower blood glucose levels.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Life for a Child Program, Diabetes Australia portfolio CI brief
• Life for a Child Program, Diabetes Australia pipeline updates RSS